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In women receiving screening mammograms at 
LVHN, is combination 2D/3D tomosynthesis better 
than 2D mammography in terms of recall rate, 
proportion of false positive recalls, ultrasound 
only recalls, and overall cancer detection in 
women with either fatty or dense breast tissue?
Problem Statement
 A total of 52,524 women were evaluated who received a screening mammogram at LVHN between May 2014 – May 2016. Of those, 30,616 received a 2D digital mammogram, while 2,530 required a call back for additional 
imaging. This resulted in an overall recall rate for 2D mammography of 8.26%. 21,908 women received 
combination 2D/3D tomosynthesis, of which 1,522 required a call back for additional imaging. This resulted in 
an overall recall rate for combination 2D/3D mammography of 6.9%. Of the women called back using 2D digital 
mammography, a total of 95 invasive cancers were detected. This amounted to 3.75% of the women called 
back. Of the women called back using combination 2D/3D tomosynthesis, a total of 89 invasive cancers were 
detected. This amounted to 5.8% of the women called back. Additionally, in women with dense breast tissue, we 
found a statistically significant reduction in the amount of false positive recalls when utilizing combination 2D/3D 
tomosynthesis (p-value 0.03).
Results
 Combination 2D/3D mammography has been shown in numerous studies to improve overall cancer detection as well as reduce the number of false positive recalls. In our study, we found that using 2D/3D tomosynthesis 
as a screening tool resulted in less women being called back unnecessarily. Of those women who were called 
back, however, tomosynthesis was able to pick up on a higher percentage of invasive cancers. When viewing 
the technology from a breast density standpoint, women with denser breast tissue benefited from a decrease in 
false positive recalls when using tomosynthesis. These results corroborate current literature as well as provide 
evidence for the benefits of combination 2D/3D tomosynthesis specifically in women with dense breast tissue.
Conclusion
In November 2014, the American College 
of Radiology released a statement saying 
combination 2D/3D tomosynthesis was no 
longer investigational, and that it has shown 
to improve key screening parameters when 
compared to 2D digital mammography. Of 
these key screening methods are things such 
as overall cancer detection, reduction in false 
positive recalls, and invasive cancer detection. 
While numerous studies have corroborated this 
information, insurance companies are lagging 
behind in terms of providing coverage, claiming 
there is not enough evidence yet to support its 
use. This doubt has crept into the public persona, 
with many women either unaware of the new 
technology or unwilling to pay out of pocket for it.
 We performed a retrospective institutional review of all women who received an initial BIRADS 
0 screening mammogram at LVHN between 
May 2014 - May2016. This study compared 
the performance of 2D mammography versus 
combination 2D/3D tomosynthesis in women 
with both normal and dense breast tissue. The 
analysis included the following performance 
metrics that were further stratified based on 
breast density: Recall rate, false positive recall 
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Figure 1. Overall recall rate in women with both fatty and 
dense breast tissue when comparing 2D to combination 2D/3D 
tomosynthesis.
Figure 2. Comparison of the proportion of false positive 
recalls in women with dense breast tissue.
Table 1. Sample Data Collection Spreadsheet
























4A 4B 4C 5 Benign DCIS IDC ILC Unresolved Other
 
May 2014 2D Total 4658 1089 68 5.88% 1 1% 43 15 10 8 1 0 1 7 2 1 0
May 2014 2D Fatty  38  1  24 9 5 5 0 0 0 5 0 0 0
May 2014 2D Dense   30 0 19 6 5 3 1 0 1 2 2 1 0
May 2014 3D Total 926 864 62 6.70% 8 13% 33 16 12 7 2 3 0 8 0 3 0 *1 cyst asp
May 2014 3D Fatty   27  3  13 7 5 4 0 1 0 4 0 1 0 *1 cyst asp
May 2014 3D Dense   35    20 8 7 3 2 2 0 5 0 2 0 *1 cyst asp
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